ADIPOQ and renal cell carcinoma: Multiple epidemiological studies have investigated the association between circulating adiponectin concentration and cancer risk with inverse relationships sometimes reported for endometrial, colorectal, renal cell carcinoma (RCC) and pancreatic cancer.3, 7, 8, 9, 10